Lefa Seran SNF: Psychotropic Drug Monitoring Failure - NV
The resident, identified in inspection records only as Resident 18, was admitted with an unspecified brain disorder. By December 2024, the resident had begun showing signs of terminal agitation: hallucinations, decreased communication, a fading appetite, sleeping for longer and longer stretches, and a growing sensitivity to light.
On April 3, 2025, a physician ordered Lorazepam, a benzodiazepine, at 0.5 milliliters by mouth every four hours as needed for terminal agitation, for a 14-day course. Lorazepam carries risks that include respiratory depression, excessive sedation, and paradoxical agitation, particularly in elderly patients. In a person already experiencing the neurological and physical deterioration that accompanies terminal illness, those risks are not theoretical.
The facility kept a binder at the nurse's station specifically for tracking behavior and side effects in residents on psychotropic medications. Inspectors checked it. Resident 18 was not in it.
The Assistant Director of Nursing, interviewed at 9:23 that morning, confirmed the gap without dispute. All residents on psychotropic medications required behavior and side effect monitoring, she said. The binder was where that monitoring lived. And the binder had nothing for Resident 18's Lorazepam.
An hour later, at 10:31 AM, the Director of Nursing said the same thing more plainly: monitoring for Resident 18 had not yet begun.
That afternoon, at 1:28 PM, the Director of Nursing offered context. The Lorazepam was being used to manage Resident 18's terminal agitation. The symptoms had started months earlier. But neither the timing of the diagnosis nor the nature of the drug changed what inspectors had already confirmed: in the days since the order was written, nobody had opened a monitoring form.
The facility's own psychotropic medication policy, last revised in April 2023, required licensed nurses to be aware of potential side effects and directed all medical and nursing staff to evaluate the effectiveness of as-needed psychotropic drugs in managing behavior. The policy existed. The monitoring did not.
Inspectors classified the violation as causing minimal harm or potential for actual harm, and noted it affected few residents. One resident, in the sample of 12 reviewed, had fallen through the gap.
That framing, minimal harm, can obscure what was actually at stake. Resident 18 was not in a stable, long-term phase of illness. Terminal agitation is a recognized end-of-life phenomenon, and the medications used to treat it require careful titration and observation precisely because patients in that condition are often unable to report what they are experiencing. Hallucinations, sensitivity to light, and decreased communication had already been documented. The monitoring system that existed to catch changes in those symptoms, or to flag whether the drug was helping or causing new harm, was simply empty.
Lefa Seran SNF is a small facility on 1st and A Street in Hawthorne, a town of roughly 3,000 people in Mineral County, one of the most remote stretches of Nevada. The nearest major medical center is hours away. In that context, the nursing staff's ability to observe and document what a dying resident on a sedative is experiencing is not a bureaucratic checkbox. It is the closest thing to a safety net that resident has.
The inspection report does not say whether Resident 18's condition changed during the days Lorazepam was given without monitoring. It does not say whether the drug helped. What the record shows is that two senior nursing leaders, asked directly on the day inspectors arrived, confirmed the same fact: the monitoring had not started. Neither offered an explanation for why.
Resident 18 was still a patient at the facility when inspectors documented the deficiency. The report does not say what happened after that.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Lefa Seran Snf from 2025-04-10 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: This article is based on inspection data downloaded directly from the Centers for Medicare & Medicaid Services (CMS) via Medicare.gov. CMS releases inspection reports in bulk; we publish the findings as documented by state surveyors in the official Form CMS-2567 Statement of Deficiencies.
Plan of correction: The CMS report we receive does not include the facility's plan of correction. Facilities submit plans of correction separately to state survey agencies and those responses may not be reflected in CMS data at the time of publication. The absence of a plan of correction in our data does not mean one was not filed. Readers who want information about corrective steps taken are encouraged to contact the facility directly or their state survey agency.
Corrections may have occurred: Inspection reports reflect conditions observed on the date of the survey. Facilities may have implemented corrections, staffing changes, additional training, or other remediation since the report was issued. We report what CMS provides and encourage readers to seek current information from the facility.
Editorial process: Inspection findings are extracted from CMS source documents and synthesized using AI, reviewed for factual accuracy against the original report by our editorial team.
Corrections: We strive for accuracy in everything we publish. If you believe any fact in this article is incorrect, please contact us with details, and we will review and correct it promptly.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: October 29, 2026 · Our methodology
LEFA SERAN SNF in HAWTHORNE, NV was cited for violations during a health inspection on April 10, 2025.
The resident, identified in inspection records only as Resident 18, was admitted with an unspecified brain disorder.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.